Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Current Opinion in HIV and AIDS|October 5, 2018
HIV-associated pediatric tuberculosis: prevention, diagnosis and treatmentAlexander Kay, Anthony J Garcia-Prats, Anna Maria Mandalakas
Pharmaceutics|March 28, 2026
Differentiating Resistance from Formulation Failure: Isoniazid Instability and Poor Dissolution in Crushed Multi-Drug Paediatric PreparationsHalima Samsodien, Jana Winkler, Marique Aucamp, et al.
Expert Opinion on Drug Safety|August 23, 2016
The safety and tolerability of the second-line injectable antituberculosis drugs in childrenAnthony J Garcia-Prats, H Simon Schaaf, Anneke C Hesseling
Journal of the International AIDS Society|December 8, 2015
Tuberculosis: opportunities and challenges for the 90-90-90 targets in HIV-infected childrenHelena Rabie, Lisa Frigati, Anneke C Hesseling, et al.
South African Journal of Psychology = Suid-Afrikaanse Tydskrif Vir Sielkunde|August 30, 2021
Caregiver-child separation during tuberculosis hospitalisation: a qualitative study in South AfricaKyla A Meyerson, Graeme Hoddinott, Anthony J Garcia-Prats, et al.
Expert Review of Clinical Pharmacology|December 28, 2017
Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in childrenH Simon Schaaf, Anthony J Garcia-Prats, Lindsay McKenna, et al.
Journal of the Pediatric Infectious Diseases Society|October 31, 2022
Tuberculosis in Children Living With HIV: Ongoing Progress and ChallengesBryan J Vonasek, Helena Rabie, Anneke C Hesseling, et al.
Tuberculosis (Edinburgh, Scotland)|January 7, 2014
Linezolid for the treatment of drug-resistant tuberculosis in children: a review and recommendationsAnthony J Garcia-Prats, Penelope C Rose, Anneke C Hesseling, et al.
Current Opinion in Infectious Diseases|April 23, 2014
Managing multidrug-resistant tuberculosis in children: review of recent developmentsH Simon Schaaf, Anthony J Garcia-Prats, Anneke C Hesseling, et al.
Plos Medicine|August 16, 2019
Inclusion of key populations in clinical trials of new antituberculosis treatments: Current barriers and recommendations for pregnant and lactating women, children, and HIV-infected personsAmita Gupta, Michael D Hughes, Anthony J Garcia-Prats, et al.
Pageof 8